CN104447724A - 一种雷替曲塞的精制方法 - Google Patents
一种雷替曲塞的精制方法 Download PDFInfo
- Publication number
- CN104447724A CN104447724A CN201410844732.9A CN201410844732A CN104447724A CN 104447724 A CN104447724 A CN 104447724A CN 201410844732 A CN201410844732 A CN 201410844732A CN 104447724 A CN104447724 A CN 104447724A
- Authority
- CN
- China
- Prior art keywords
- raltitrexed
- purification
- crude product
- temperature
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IVTVGDXNLFLDRM-HNNXBMFYSA-N Tomudex Chemical compound C=1C=C2NC(C)=NC(=O)C2=CC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)S1 IVTVGDXNLFLDRM-HNNXBMFYSA-N 0.000 title claims abstract description 65
- 229960004432 raltitrexed Drugs 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 26
- 238000007670 refining Methods 0.000 title abstract description 18
- 239000007787 solid Substances 0.000 claims abstract description 29
- 239000012043 crude product Substances 0.000 claims abstract description 24
- 238000005406 washing Methods 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000003756 stirring Methods 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 9
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 60
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- 238000000746 purification Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000009413 insulation Methods 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- -1 methyl-formiate Chemical compound 0.000 claims description 4
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000012535 impurity Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 238000010992 reflux Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 102000005497 Thymidylate Synthase Human genes 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844732.9A CN104447724B (zh) | 2014-12-31 | 2014-12-31 | 一种雷替曲塞的精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844732.9A CN104447724B (zh) | 2014-12-31 | 2014-12-31 | 一种雷替曲塞的精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104447724A true CN104447724A (zh) | 2015-03-25 |
CN104447724B CN104447724B (zh) | 2017-11-10 |
Family
ID=52894543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410844732.9A Active CN104447724B (zh) | 2014-12-31 | 2014-12-31 | 一种雷替曲塞的精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104447724B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106957312A (zh) * | 2016-12-29 | 2017-07-18 | 南京正大天晴制药有限公司 | 雷替曲塞水合物晶型及其制备方法 |
CN106957311A (zh) * | 2016-12-29 | 2017-07-18 | 南京正大天晴制药有限公司 | 雷替曲塞的溶剂化物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0239362A2 (en) * | 1986-03-27 | 1987-09-30 | Imperial Chemical Industries Plc | Anti-tumor agents |
CN102127063A (zh) * | 2011-01-06 | 2011-07-20 | 深圳市普迈达科技有限公司 | 抗癌药物雷替曲塞的合成新工艺 |
CN102424679A (zh) * | 2011-11-15 | 2012-04-25 | 扬子江药业集团有限公司 | 一种雷替曲塞的制备方法 |
WO2012074496A1 (en) * | 2010-12-03 | 2012-06-07 | Kocak Farma Ilac Ve Kimya San. A.S | A new method for producing antifolate agents having glutamic acid part in their structure |
CN103570702A (zh) * | 2012-07-26 | 2014-02-12 | 南京优科生物医药有限公司 | 一种适合工业化制备雷替曲塞的方法及适于药用的新晶型 |
-
2014
- 2014-12-31 CN CN201410844732.9A patent/CN104447724B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0239362A2 (en) * | 1986-03-27 | 1987-09-30 | Imperial Chemical Industries Plc | Anti-tumor agents |
WO2012074496A1 (en) * | 2010-12-03 | 2012-06-07 | Kocak Farma Ilac Ve Kimya San. A.S | A new method for producing antifolate agents having glutamic acid part in their structure |
CN102127063A (zh) * | 2011-01-06 | 2011-07-20 | 深圳市普迈达科技有限公司 | 抗癌药物雷替曲塞的合成新工艺 |
CN102424679A (zh) * | 2011-11-15 | 2012-04-25 | 扬子江药业集团有限公司 | 一种雷替曲塞的制备方法 |
CN103570702A (zh) * | 2012-07-26 | 2014-02-12 | 南京优科生物医药有限公司 | 一种适合工业化制备雷替曲塞的方法及适于药用的新晶型 |
Non-Patent Citations (5)
Title |
---|
MARSHAM, PETER R.,ET AL.: "Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications", 《 JOURNAL OF MEDICINAL CHEMISTRY 》 * |
PETER R. MARSHAM,ET AL.: "Design and Synthesis of Potent Non-Polyglutamatable Quinazoline Antifolate Thymidylate Synthase Inhibitors", 《JOURNAL OF MEDICINAL CHEMISTRY 》 * |
李亮,等: "6-溴甲基-2-甲基-3(H)-喹唑啉-4-酮的合成", 《化学研究与应用》 * |
虞心红,等: "胸苷酸合成酶抑制剂雷替曲塞的合成", 《华东理工大学学报(自然科学版)》 * |
郝春明,等: "抗癌药雷替曲塞的合成", 《中国药物化学杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106957312A (zh) * | 2016-12-29 | 2017-07-18 | 南京正大天晴制药有限公司 | 雷替曲塞水合物晶型及其制备方法 |
CN106957311A (zh) * | 2016-12-29 | 2017-07-18 | 南京正大天晴制药有限公司 | 雷替曲塞的溶剂化物及其制备方法 |
CN106957312B (zh) * | 2016-12-29 | 2019-11-01 | 南京正大天晴制药有限公司 | 雷替曲塞水合物晶型及其制备方法 |
CN106957311B (zh) * | 2016-12-29 | 2020-03-31 | 南京正大天晴制药有限公司 | 雷替曲塞的溶剂化物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104447724B (zh) | 2017-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101941969B (zh) | 盐酸莫西沙星的制备方法 | |
CN104402838B (zh) | 缬沙坦的精制方法 | |
CN106256824A (zh) | 一种高纯度德拉沙星葡甲胺盐的制备方法 | |
CN102002082A (zh) | 一种黄芩苷的制备方法 | |
CN101704766B (zh) | 精氨酸阿司匹林及其粉针剂的制备方法 | |
CN103570663A (zh) | 一种高纯度槲皮素的制备方法 | |
CN104447724A (zh) | 一种雷替曲塞的精制方法 | |
CN102391128B (zh) | 一种抗生素医药中间体丙二酸单对硝基苄酯的生产方法 | |
CN104529935B (zh) | 2‑(3‑醛基‑4‑异丁氧基苯基)‑4‑甲基噻唑‑5‑甲酸乙酯的合成方法 | |
CN103044468B (zh) | N-(2-吡嗪羰基)-l-苯丙氨酸-l-亮氨酸硼酸的制备方法 | |
CN104496937A (zh) | 头孢他啶侧链酸活性酯的合成方法 | |
CN104557576A (zh) | 一种高纯度普瑞巴林的制备方法 | |
CN101870704B (zh) | 一种头孢替坦酸粗品的纯化方法 | |
CN103319548A (zh) | 一种蔗糖-6-乙酸酯的提纯方法 | |
CN103664812A (zh) | 一种2,5-二氢-6-羟基-2-甲基-5-氧-3-巯基-1,2,4-三嗪的制备方法 | |
CN102850290A (zh) | 晶型i型利奈唑胺的制备方法 | |
CN102731383A (zh) | 一种3-甲基-6-氯-2-甲酸甲酯吡啶的合成方法 | |
CN103772454B (zh) | 克林霉素磷酸酯的精制方法 | |
CN103570522B (zh) | 一种99.5%甲酸钠的生产方法 | |
CN102964396B (zh) | 一种三氯蔗糖-6-乙酯重结晶的方法 | |
CN101875603B (zh) | 截短侧耳素类抗生素合成中间体姆替林的制备方法 | |
CN102731340B (zh) | 去甲基金霉素盐酸盐制备方法 | |
CN107304187B (zh) | 一种奥拉帕尼的重结晶方法 | |
CN103755726A (zh) | 一种头孢洛宁的精制提纯方法 | |
CN103420882B (zh) | 一种l-蛋氨酸的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 614000 Yingbin Avenue, Central District, Sichuan, Leshan, No. 6 Applicant after: Emei Mountain in Sichuan Pharmaceutical Co. Ltd. Address before: 614000 Yingbin Avenue, Central District, Sichuan, Leshan, No. 6 Applicant before: SICHUAN EMEISHAN PHARMACEUTICAL CO., LTD. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Refining method of raltitrexed Effective date of registration: 20200421 Granted publication date: 20171110 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co., Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2020980001669 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210414 Granted publication date: 20171110 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co.,Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2020980001669 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A refining method of raltitrexed Effective date of registration: 20210521 Granted publication date: 20171110 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co.,Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2021510000072 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |